Coronavirus LIVE Updates: Moderna's COVID-19 vaccine won't be ready before US election, says company CEO

-

10:07 (IST)

Coronavirus in India LATEST Updates

India’s tally touches 65-lakh mark with almost 76,000 new cases today

India’s coronavirus count rose to 65,49,393 on Sunday, as the country reported 75,829 new cases in the last 24 hours. India’s toll rose by 940 to 1,01,782.

So far, more than 55 lakh people have recovered from the virus in India. The recovery rate is around 83% now.

09:31 (IST)

Coronavirus in US LATEST Updates

Moderna's COVID-19 vaccine won't be ready before US election, says CEO

US biotech firm Moderna won't seek an emergency use authorization for its coronavirus vaccine before November 25, its CEO told the Financial Times on Wednesday.

The news deals a blow to President Donald Trump's hopes of having an injection ready before the election to give his campaign a much-needed boost.

Stephane Bancel told the newspaper: "November 25 is the time we will have enough safety data to be able to put into an EUA file that we would send to the FDA (Food and Drug Administration) - assuming that the safety data is good, i.e. a vaccine is deemed to be safe."

Trump, whose approval has taken a hit over his handling of the Covid-19 crisis, has frequently hinted a vaccine could be ready before the 3 November vote.

-AFP

09:21 (IST)

Coronavirus in India LATEST Updates

Harsh Vardhan to announce India's COVID-19 vaccine plan today

As the world is racing to develop a potential vaccine against Covid-19, Union Health Minister Harsh Vardhan will today give the details about India's coronavirus vaccine plan. When will India get Covid-19 vaccination? Who will be vaccinated first in the country and many other such questions will be answered by the Union Health Minister in today's Samvaad programme.

09:13 (IST)

Coronavirus in US LATEST Updates

Trump says he is 'starting to feel good' and vows 'to be back' soon

US President Donald Trump posted a video Saturday from the hospital where he is battling COVID-19, saying he was improving and would be "back soon" — but acknowledging the crucial coming days would be "the real test."

"I came here, wasn't feeling so well. I feel much better now," Trump said from his business suite at Walter Reed military medical center near Washington.

"We're working hard to get me all the way back... I think I'll be back soon and I look forward to finishing up the campaign the way it was started."

Read full report here

09:07 (IST)

Coronavirus in India LATEST Updates

India tops global ranking with maximum COVID-19 recoveries, lowest mortality rate

India continues to occupy the top global position with the maximum number of COVID-19 recoveries and accounts for 21 percent of the recovered cases worldwide, while its share in the total cases stands at 18.6 percent, the Union Health Ministry said today.

India has also maintained its global position with one of the lowest COVID-19 case fatality rates (CFR) when compared to several other countries.

While the global CFR stands at 2.97 percent as on today, the comparative figure for India is 1.56 percent, it said.

The deaths per million population in India is one of the lowest in the world. While the global average is 130 deaths per million population, India is reporting 73 deaths per million population, the ministry said.

09:00 (IST)

Coronavirus in Odisha LATEST Updates

COVID-19 positive BJD leader Pradeep Maharathy put on ventilator support

Senior BJD leader and Pipili MLA Pradeep Maharathy, who had tested positive for COVID-19, was put on ventilator support after his health condition deteriorated, the ruling party in Odisha said on Saturday. Maharathy, also a former minister, tested positive on 14 September.

Chief Minister Naveen Patnaik has spoken to his family members and prayed for the lawmaker's speedy recovery, a BJD statement said. Maharathy is among the 51 lawmakers of the state to have contracted the virus.

Meanwhile, Patnaik also congratulated Shehnaz Begum, a nonagenarian from Sambalpur, on recovering from COVID-19.

Coronavirus LATEST Updates: US biotech firm Moderna won't seek an emergency use authorization for its coronavirus vaccine before November 25, its CEO told the Financial Times. The news deals a blow to President Donald Trump's hopes of having an injection ready before the election to give his campaign a much-needed boost.

India's COVID-19 toll crossed one lakh and the infection tally climbed to 64,73,544, while the number of people who have recuperated from the disease crossed 54 lakh, pushing the recovery rate to 83.84 percent, the Union Health Ministry said on Saturday.

India reported 79,476 new infections on Saturday, while 1,069 died in a span of 24 hours taking the nationwide toll from the virus to 1,00,842, data updated at 8 am showed.

The total recoveries have surged to 54,27,706, while there are 9,44,996 active cases of coronavirus infection in the country which comprises 14.60 percent of the total caseload, the data showed.

The COVID-19 case fatality rate was recorded at 1.56 percent.

Meanwhile, the global tally of coronavirus cases stands at 34,817,275. While 25,879,985 have recovered, 1,032,708 have died so far. The US, the worst-hit country, has 75,49,076 cases. It is followed by India, which has 64,71,734 cases, Brazil (48,82,231) and Russia (11,94,643).

India tops global ranking with maximum Covid-19 recoveries, lowest mortality rate

India continues to occupy the top global position with the maximum number of COVID-19 recoveries and accounts for 21 percent of the recovered cases worldwide, while its share in the total cases stands at 18.6 percent, the Union Health Ministry said today.

India has also maintained its global position with one of the lowest COVID-19 case fatality rates (CFR) when compared to several other countries.

While the global CFR stands at 2.97 percent as on today, the comparative figure for India is 1.56 percent, it said.

The deaths per million population in India is one of the lowest in the world. While the global average is 130 deaths per million population, India is reporting 73 deaths per million population, the ministry said.

Trump undergoing Remdesivir therapy at military hospital; says 'doing well'

US President Donald Trump's condition has been "very concerning" over the last 24 hours, a source familiar with his health told AFP on Saturday, adding that the coming 48 hours would be critical.

"The president's vitals over the last 24 hours were very concerning and the next 48 hours will be critical in terms of his care. We're still not on a clear path to a full recovery," the news agency quoted the source as saying.

The assessment is at odds with the more optimistic picture presented by Trump's medical team, who said he was breathing well without oxygen and improving.

According to reports, the US president was given Remdesivir therapy at the hospital.

Trump, 74, and his wife US First Lady Melania Trump, 50, tested positive for COVID-19 on Friday.

"Going well, I think! Thank you to all. LOVE!!!" Trump tweeted on Saturday.

While Trump, who showed "mild symptoms" of COVID-19, was flown to Walter Reed Military Medical Centre in Bethesda, a Maryland suburb of Washington DC, on Friday, the first lady stayed back at the White House.

Oxford vaccine could be rolled out within six months, says report

There is growing hope that a vaccine against the novel coronavirus may be given the green light by health regulators by the end of this year to be rolled out for a vaccination programme in six months' time or even less, according to a UK media report.

The vaccine candidate under trial by University of Oxford scientists in collaboration with pharmaceutical giant AstraZeneca is the furthest in the process of trials and, according to a report in The Times, it could be given the required clearances by Christmas in December.

The newspaper quoted UK government sources involved in the making and distribution of vaccines as saying that a full vaccine roll-out programme for adults could take six months or less after approval.

We are looking at closer to six months and it is likely to be far shorter than that, a government source said.

According to the newspaper report, scientists on the trial are hopeful that they will get results before the end of this year, and that they will, at the very least show that it prevents 50 percent of infections, the threshold for success.

Jharkhand Minister dies after defeating coronavirus

A day after testing negative for coronavirus, Jharkhand Minority Welfare Minister Haji Hussain Ansari passed away on Saturday at the Medanta Hospital in Ranchi, a JMM leader said.

According to Jharkhand Mukti Morcha spokesperson Supriyo Bhattacharya, Ansari's coronavirus report had come negative on Friday.

The 73-year-old leader was made minister for the second time in January this year in the Hemant Soren's government.

He was admitted in the hospital for treatment of coronavirus earlier on. He complained of breathing problem on Saturday.

25 states/UTs report fall in active COVID-19 cases in last week

As many as 25 states and union territories (UTs) have reported a fall in the number of active cases during the last week, said the Union Ministry of Health and Family Welfare (MoHFW) on Saturday.

"25 States/UTs have reported a fall in the number of Active Cases during the last week. Higher number of daily recoveries and persistently regressing fatality rate are leading to the lower number of active cases on a daily basis," the Ministry tweeted.

At least 76.62 percent of the active coronavirus cases have been reported from 10 states and UTs, it said on Friday.

Maharashtra is leading the states' tally with more than 2.5 lakh cases, the government informed, adding that active cases contribute only 14.74 per cent to the positive caseload of the country.

India's COVID-19 tally had crossed the 20-lakh mark on 7 August, 30 lakh on 23 August and 40 lakh on 5 September. It went past 50 lakh on 16 September and crossed 60 lakh on 28 September.

According to the Indian Council of Medical Research (ICMR), a cumulative total of 7,78,50,403 samples have been tested up to 2 October, of which 11,32,675 were tested on Friday.

The 1,069 new fatalities include 424 from Maharashtra, 125 from Karnataka, 67 from Tamil Nadu, 53 each from Uttar Pradesh and West Bengal, 50from Punjab, 37 from Delhi, 36 from Madhya Pradesh, and 31 from Andhra Pradesh.

The 1,00,842 deaths reported so far in India includes 37,480 from Maharashtra, followed by 9,653 from Tamil Nadu, 9,119 from Karnataka, 5,917 from Uttar Pradesh, 5,900 from Andhra Pradesh, 5,438 from Delhi, 5,070 from West Bengal, 3,501 from Punjab, and 3,475 from Gujarat.

The health ministry stressed that more than 70 percent of the deaths occurred due to comorbidities.

With inputs from PTI



from Firstpost India Latest News https://ift.tt/3juVWFF
FP Staff

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

Aditya L1 Mission: Spacecraft is nearing its final phase, says ISRO chief

-
Aditya L1 spacecraft is nearing its final phase, and manoeuvres to enter the L1 point are expected to be completed by January 7, 2024, according to ISRO Chairman S Somanath. “Aditya is on the way. I think it has reached almost its final phase,” the ISRO chief told PTI on the sidelines of an event organised at VSSC to commemorate the 60th year of the First Sounding Rocket Launch. Aditya L1, India’s first space-based mission to study the Sun, was successfully launched on September 2 from the Satish Dhawan Space Centre (SDSC) in Sriharikota. The spacecraft, after travelling about 1.5 million km from Earth over 125 days, is expected to be placed in a Halo orbit around the Lagrangian point L1, considered closest to the Sun. He said that the last preparations for the spacecraft’s entry into the L1 point are currently underway incrementally.”Possibly by January 7th, the final manoeuvres will be done for entering into the L1 point,” Somanath added. Among other tasks, it will capture and tr
Read more